Clinton Medical Records Privacy Proposal

Publication
Article
OncologyONCOLOGY Vol 13 No 12
Volume 13
Issue 12

Physician groups are apt to seize on two aspects of the Clintonmedical records privacy proposal, which came out at the end of October and is expected to be finalized in February. The proposal

Physician groups are apt to seize on two aspects of the Clintonmedical records privacy proposal, which came out at the end of October and is expected to be finalized in February. The proposal basically says that a patient’s “identifiable” information can be transferred from physician to insurance company to hospital and others in the health provider chain—without the patient’s consent—as long as the information is being used for medical treatment, billing, or health-related business operations. ASCO agrees with the first two purposes, but opposes an “expansive” definition of health care operations. The second key issue relates to the fact that the Clinton proposal simply sets a federal “floor.” State laws must be at least as protective, but they also can have more restrictive provisions. ASCO wants any federal standard to preempt all state laws. Contacted soon after the proposal was released, Julie Taylor at ASCO said the group is in the process of combing through the 600+ page proposal.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content